Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis

BACKGROUND: A new prolonged-release formulation of potassium citrate and potassium bicarbonate, ADV7103, has been shown to improve metabolic control, palatability, and gastrointestinal safety in patients with distal renal tubular acidosis (dRTA) when compared to standard of care (SoC) treatments. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertholet-Thomas, Aurélia, Guittet, Catherine, Manso-Silván, Maria A., Joukoff, Sophie, Navas-Serrano, Victor, Baudouin, Véronique, Cailliez, Mathilde, Di Maio, Massimo, Gillion-Boyer, Olivia, Golubovic, Emilija, Harambat, Jérôme, Knebelmann, Bertrand, Nobili, François, Novo, Robert, Podracka, Ludmila, Roussey-Kesler, Gwenaëlle, Granier, Luc-André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172410/
https://www.ncbi.nlm.nih.gov/pubmed/33635379
http://dx.doi.org/10.1007/s00467-020-04873-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172410/
https://www.ncbi.nlm.nih.gov/pubmed/33635379
http://dx.doi.org/10.1007/s00467-020-04873-0

Ejemplares similares